Achieving Precision: Inside the NIOX® Sweden Lab's Advanced Testing Techniques

Discover the cutting-edge testing methods used at the NIOX® Lab in Sweden. In this exclusive behind-the-scenes tour, we dive deep into the advanced technologies and rigorous processes that ensure the highest accuracy and reliability of our results. From the meticulous calibration of instruments to the innovative approaches in respiratory testing, see how our dedicated team is committed to delivering robust and trustworthy results every time.
This video is intended for healthcare professionals.
NIOX Group plc is a company that specialises in the development, manufacture, and distribution of medical devices for the diagnosis and monitoring of asthma. Their flagship product, NIOX VERO®, is a non-invasive medical device that measures fractional exhaled nitric oxide (FeNO) levels in patients with asthma.
NIOX VERO® provides accurate and reliable results, allowing healthcare professionals to make informed decisions about the diagnosis and management of asthma. It is easy to use1, with a simple touch screen interface and intuitive design, and can be used in a variety of settings, including clinics, hospitals, and primary care settings.
The NIOX Group plc is committed to improving the lives of people with asthma and is dedicated to innovation and excellence in its products and services. NIOX® is also committed to offering additional training and support for healthcare professionals.
Overall, NIOX Group plc is the global leader in FeNO testing, with a strong reputation for innovation and excellence in the development of medical devices for the diagnosis and management of asthma. With NIOX VERO®, healthcare professionals have a reliable and non-invasive1 tool to help them better diagnose and manage asthma.
Find out more about NIOX VERO® here:
niox.com
MKT-PRM-WW-0371